Listed

Natural Health Trends Corp

NHTCNasdaqCIK 912061Consumer discretionaryFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$7.6m, Q3 FY2026
Operating income−$277.0k, Q3 FY2026
Net income−$232.0k, Q3 FY2026
Natural Health Trends Corp, income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m10.9Revenue, Q4 FY2023, three months to 2023-12-31$10.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure11.0Revenue, Q1 FY2024, three months to 2024-03-31$11.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure10.5Revenue, Q2 FY2024, three months to 2024-06-30$10.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure10.7Revenue, Q3 FY2024, three months to 2024-09-30$10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure10.8Revenue, Q4 FY2024, three months to 2024-12-31$10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure10.7Revenue, Q1 FY2025, three months to 2025-03-31$10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure9.8Revenue, Q2 FY2025, three months to 2025-06-30$9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure9.5Revenue, Q3 FY2025, three months to 2025-09-30$9.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure9.7Revenue, Q4 FY2025, three months to 2025-12-31$9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure9.2Revenue, Q1 FY2026, three months to 2026-03-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure7.6Revenue, Q2 FY2026, three months to 2026-06-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure7.6Revenue, Q3 FY2026, three months to 2026-09-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Cost of revenue$m2.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure2.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$2.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure2.7Cost of revenue, Q2 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure2.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure2.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure2.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure2.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$2.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure2.5Cost of revenue, Q3 FY2025, three months to 2025-09-30$2.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure2.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure2.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure1.9Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure2.0Cost of revenue, Q3 FY2026, three months to 2026-09-30$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Gross profit$m8.1Gross profit, Q4 FY2023, three months to 2023-12-31$8.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure8.0Gross profit, Q1 FY2024, three months to 2024-03-31$8.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure7.8Gross profit, Q2 FY2024, three months to 2024-06-30$7.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure7.9Gross profit, Q3 FY2024, three months to 2024-09-30$7.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure8.0Gross profit, Q4 FY2024, three months to 2024-12-31$8.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure7.9Gross profit, Q1 FY2025, three months to 2025-03-31$7.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure7.3Gross profit, Q2 FY2025, three months to 2025-06-30$7.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure7.0Gross profit, Q3 FY2025, three months to 2025-09-30$7.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure7.1Gross profit, Q4 FY2025, three months to 2025-12-31$7.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure6.9Gross profit, Q1 FY2026, three months to 2026-03-31$6.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure5.7Gross profit, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure5.6Gross profit, Q3 FY2026, three months to 2026-09-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Selling, general and administrative$m3.8Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$3.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure3.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$3.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure3.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure3.9Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure3.9Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$3.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure3.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$3.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure3.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$3.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure3.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$3.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure3.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$3.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure3.5Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure3.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure3.2Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$3.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Operating income$m(0.2)Operating income, Q4 FY2023, three months to 2023-12-31−$242.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Operating income, Q1 FY2024, three months to 2024-03-31−$365.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure(0.2)Operating income, Q2 FY2024, three months to 2024-06-30−$238.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure(0.3)Operating income, Q3 FY2024, three months to 2024-09-30−$275.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure(0.4)Operating income, Q4 FY2024, three months to 2024-12-31−$421.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(0.3)Operating income, Q1 FY2025, three months to 2025-03-31−$345.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(0.3)Operating income, Q2 FY2025, three months to 2025-06-30−$333.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.5)Operating income, Q3 FY2025, three months to 2025-09-30−$495.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(0.6)Operating income, Q4 FY2025, three months to 2025-12-31−$635.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Operating income, Q1 FY2026, three months to 2026-03-31−$474.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(0.6)Operating income, Q2 FY2026, three months to 2026-06-30−$643.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.3)Operating income, Q3 FY2026, three months to 2026-09-30−$277.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.1Income tax, Q4 FY2023, three months to 2023-12-31$108.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$108.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$131.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure(0.2)Income tax, Q4 FY2024, three months to 2024-12-31−$201.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2025, three months to 2025-03-31−$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$142.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure0.2Income tax, Q4 FY2025, three months to 2025-12-31$175.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2026, three months to 2026-03-31−$25.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(0.0)Income tax, Q2 FY2026, three months to 2026-06-30−$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure0.1Income tax, Q3 FY2026, three months to 2026-09-30$67.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Net income$m0.4Net income, Q4 FY2023, three months to 2023-12-31$358.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure0.2Net income, Q1 FY2024, three months to 2024-03-31$188.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure0.2Net income, Q2 FY2024, three months to 2024-06-30$173.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure0.0Net income, Q3 FY2024, three months to 2024-09-30$35.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure0.2Net income, Q4 FY2024, three months to 2024-12-31$176.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure0.1Net income, Q1 FY2025, three months to 2025-03-31$122.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure0.0Net income, Q2 FY2025, three months to 2025-06-30$15.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(0.4)Net income, Q3 FY2025, three months to 2025-09-30−$431.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(0.6)Net income, Q4 FY2025, three months to 2025-12-31−$588.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Net income, Q1 FY2026, three months to 2026-03-31−$154.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(0.5)Net income, Q2 FY2026, three months to 2026-06-30−$451.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(0.2)Net income, Q3 FY2026, three months to 2026-09-30−$232.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Diluted EPS$ per sharenot reported0.02Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure0.02Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure0.00Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figurenot reported0.01Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.04)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.03)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Basic EPS$ per sharenot reported0.02Basic EPS, Q1 FY2024, three months to 2024-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure0.02Basic EPS, Q2 FY2024, three months to 2024-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure0.00Basic EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figurenot reported0.01Basic EPS, Q1 FY2025, three months to 2025-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.00Basic EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.04)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.03)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure

Balance sheet

Cash and equivalents$5.8m, Q3 FY2026
Shareholders' equity$15.0m, Q3 FY2026
Natural Health Trends Corp, balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m56.2Cash and equivalents, FY2023, at 2023-12-31$56.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure25.8Cash and equivalents, Q1 FY2024, at 2024-03-31$25.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-01, accession 0001437749-24-014082.Report this figure15.6Cash and equivalents, Q2 FY2024, at 2024-06-30$15.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-31, accession 0001437749-24-024000.Report this figure22.9Cash and equivalents, Q3 FY2024, at 2024-09-30$22.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0001437749-24-032546.Report this figure13.5Cash and equivalents, FY2024, at 2024-12-31$13.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure21.7Cash and equivalents, Q1 FY2025, at 2025-03-31$21.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure10.5Cash and equivalents, Q2 FY2025, at 2025-06-30$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure14.3Cash and equivalents, Q3 FY2025, at 2025-09-30$14.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure6.8Cash and equivalents, FY2025, at 2025-12-31$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure9.2Cash and equivalents, Q1 FY2026, at 2026-03-31$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure9.5Cash and equivalents, Q2 FY2026, at 2026-06-30$9.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure5.8Cash and equivalents, Q3 FY2026, at 2026-09-30$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Current assets$m64.2Current assets, FY2023, at 2023-12-31$64.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure62.7Current assets, Q1 FY2024, at 2024-03-31$62.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0001437749-24-014082.Report this figure56.9Current assets, Q2 FY2024, at 2024-06-30$56.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-31, accession 0001437749-24-024000.Report this figure53.8Current assets, Q3 FY2024, at 2024-09-30$53.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0001437749-24-032546.Report this figure51.0Current assets, FY2024, at 2024-12-31$51.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure48.8Current assets, Q1 FY2025, at 2025-03-31$48.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure40.9Current assets, Q2 FY2025, at 2025-06-30$40.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure37.9Current assets, Q3 FY2025, at 2025-09-30$37.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure34.2Current assets, FY2025, at 2025-12-31$34.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure26.5Current assets, Q1 FY2026, at 2026-03-31$26.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure23.7Current assets, Q2 FY2026, at 2026-06-30$23.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure22.0Current assets, Q3 FY2026, at 2026-09-30$22.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Total assets$m69.1Total assets, FY2023, at 2023-12-31$69.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure67.6Total assets, Q1 FY2024, at 2024-03-31$67.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0001437749-24-014082.Report this figure61.5Total assets, Q2 FY2024, at 2024-06-30$61.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-31, accession 0001437749-24-024000.Report this figure58.3Total assets, Q3 FY2024, at 2024-09-30$58.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0001437749-24-032546.Report this figure55.4Total assets, FY2024, at 2024-12-31$55.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure53.2Total assets, Q1 FY2025, at 2025-03-31$53.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure45.2Total assets, Q2 FY2025, at 2025-06-30$45.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure42.3Total assets, Q3 FY2025, at 2025-09-30$42.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure38.4Total assets, FY2025, at 2025-12-31$38.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure32.0Total assets, Q1 FY2026, at 2026-03-31$31.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure29.2Total assets, Q2 FY2026, at 2026-06-30$29.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure27.3Total assets, Q3 FY2026, at 2026-09-30$27.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Current liabilities$m20.0Current liabilities, FY2023, at 2023-12-31$20.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure20.9Current liabilities, Q1 FY2024, at 2024-03-31$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0001437749-24-014082.Report this figure22.1Current liabilities, Q2 FY2024, at 2024-06-30$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-31, accession 0001437749-24-024000.Report this figure21.1Current liabilities, Q3 FY2024, at 2024-09-30$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0001437749-24-032546.Report this figure20.8Current liabilities, FY2024, at 2024-12-31$20.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure20.7Current liabilities, Q1 FY2025, at 2025-03-31$20.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure14.9Current liabilities, Q2 FY2025, at 2025-06-30$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure14.8Current liabilities, Q3 FY2025, at 2025-09-30$14.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure13.7Current liabilities, FY2025, at 2025-12-31$13.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure13.2Current liabilities, Q1 FY2026, at 2026-03-31$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure11.9Current liabilities, Q2 FY2026, at 2026-06-30$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure10.3Current liabilities, Q3 FY2026, at 2026-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Total liabilities$m27.5Total liabilities, FY2023, at 2023-12-31$27.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure28.3Total liabilities, Q1 FY2024, at 2024-03-31$28.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-01, accession 0001437749-24-014082.Report this figure24.2Total liabilities, Q2 FY2024, at 2024-06-30$24.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-31, accession 0001437749-24-024000.Report this figure23.0Total liabilities, Q3 FY2024, at 2024-09-30$23.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0001437749-24-032546.Report this figure22.5Total liabilities, FY2024, at 2024-12-31$22.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure22.3Total liabilities, Q1 FY2025, at 2025-03-31$22.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure16.3Total liabilities, Q2 FY2025, at 2025-06-30$16.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure16.1Total liabilities, Q3 FY2025, at 2025-09-30$16.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure15.0Total liabilities, FY2025, at 2025-12-31$15.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure15.5Total liabilities, Q1 FY2026, at 2026-03-31$15.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure14.0Total liabilities, Q2 FY2026, at 2026-06-30$14.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure12.3Total liabilities, Q3 FY2026, at 2026-09-30$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Shareholders' equity$m41.6Shareholders' equity, FY2023, at 2023-12-31$41.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure39.4Shareholders' equity, Q1 FY2024, at 2024-03-31$39.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure37.3Shareholders' equity, Q2 FY2024, at 2024-06-30$37.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure35.3Shareholders' equity, Q3 FY2024, at 2024-09-30$35.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure32.9Shareholders' equity, FY2024, at 2024-12-31$32.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure30.9Shareholders' equity, Q1 FY2025, at 2025-03-31$30.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure28.9Shareholders' equity, Q2 FY2025, at 2025-06-30$28.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure26.1Shareholders' equity, Q3 FY2025, at 2025-09-30$26.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure23.4Shareholders' equity, FY2025, at 2025-12-31$23.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure16.5Shareholders' equity, Q1 FY2026, at 2026-03-31$16.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure15.2Shareholders' equity, Q2 FY2026, at 2026-06-30$15.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure15.0Shareholders' equity, Q3 FY2026, at 2026-09-30$15.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure

Cash flow

Operating cash flow−$1.1m, Q3 FY2026
Capital expenditure$7.0k, Q3 FY2026
Share repurchases$28.0k, Q3 FY2026
Natural Health Trends Corp, cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$k(69.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$69.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure549Operating cash flow, Q1 FY2024, three months to 2024-03-31$549.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure(3,568)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001437749-25-023873. Derived: 6-month figure less the 3-month figure.Report this figure(436)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$436.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001437749-25-033153. Derived: 9-month figure less the 6-month figure.Report this figure88.0Operating cash flow, Q4 FY2024, three months to 2024-12-31$88.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure484Operating cash flow, Q1 FY2025, three months to 2025-03-31$484.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(5,635)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure113Operating cash flow, Q3 FY2025, three months to 2025-09-30$113.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure(959)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$959.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(797)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$797.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(1,364)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure(1,092)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$k14.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure11.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure19.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001437749-25-023873. Derived: 6-month figure less the 3-month figure.Report this figure7.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001437749-25-033153. Derived: 9-month figure less the 6-month figure.Report this figure20.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure16.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure4.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure43.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure5.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure115Capital expenditure, Q1 FY2026, three months to 2026-03-31$115.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure325Capital expenditure, Q2 FY2026, three months to 2026-06-30$325.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure7.0Capital expenditure, Q3 FY2026, three months to 2026-09-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure
Dividends paid$k2,304Dividends paid, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2025-02-21, accession 0001437749-25-004700. Derived: 12-month figure less the 9-month figure.Report this figure2,303Dividends paid, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure2,303Dividends paid, Q2 FY2024, three months to 2024-06-30$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-07-30, accession 0001437749-25-023873. Derived: 6-month figure less the 3-month figure.Report this figure2,303Dividends paid, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-05, accession 0001437749-25-033153. Derived: 9-month figure less the 6-month figure.Report this figure2,304Dividends paid, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure2,303Dividends paid, Q1 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure2,303Dividends paid, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure2,303Dividends paid, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure2,301Dividends paid, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure858Dividends paid, Q1 FY2026, three months to 2026-03-31$858.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure858Dividends paid, Q2 FY2026, three months to 2026-06-30$858.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure0.0Dividends paid, Q3 FY2026, three months to 2026-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reported0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figurenot reported5,870Share repurchases, Q1 FY2026, three months to 2026-03-31$5.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure28.0Share repurchases, Q3 FY2026, three months to 2026-09-30$28.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)8.58m, Q3 FY2026
Natural Health Trends Corp, shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares11.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3111,428,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0001437749-24-014082.Report this figure11.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3011,432,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-31, accession 0001437749-24-024000.Report this figure11.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3011,454,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-30, accession 0001437749-24-032546.Report this figure11.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3111,474,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-30, accession 0001437749-25-013645.Report this figure11.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3011,483,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001437749-25-023873.Report this figure11.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3011,490,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001437749-25-033153.Report this figure11.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3111,491,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure11.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3011,497,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure11.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3011,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure10.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,143,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure8.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-308,578,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure8.6Diluted shares (weighted), Q3 FY2026, three months to 2026-09-308,577,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure

Shares outstanding: 8.49mShares outstanding, period not labelled, at 2026-10-238,492,557 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure at Oct 23, 2026, from the cover of the 10-Q filed Oct 28, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 28, 2026, 09:27 ET. Listed shows no prices and gives no investment advice.